NewLimit

Private

South San Francisco-based longevity biotech using epigenetic reprogramming (Yamanaka-style) to restore youthful cell function. Lead program targets aged human liver cells; first clinical trial planned for 2027. Co-founded 2021 by Coinbase CEO Brian Armstrong, ex-GV's Blake Byers, and computational biologist Jacob Kimmel.

Founders Jacob Kimmel, Brian Armstrong, Blake Byers
CEO Jacob Kimmel

Company

Founded
2021
Headquarters
South San Francisco, USA

Financials

Total Funding
$605M
Sectors
Artificial Intelligence Healthtech Biotech
newlimit.com

Funding History

3 rounds
Series C Jun 2, 2026
$435M
Founders Fund (Lead) Thrive Capital Greenoaks Quiet Capital Kleiner Perkins Abstract Ventures Nat Friedman Daniel Gross Valor Equity Partners Eli Lilly Ventures Human Capital
Series B May 1, 2025
$130M
Kleiner Perkins (Lead) Nat Friedman Daniel Gross Khosla Ventures Founders Fund Dimension Capital Elad Gil Garry Tan Patrick Collison
Seed Jul 1, 2022
$40M
Founders Fund (Lead) Dimension Capital Elad Gil Garry Tan Patrick Collison

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.